Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain.

Deguchi K, Miyazaki K, Tian F, Liu N, Liu W, Kawai H, Omote Y, Kono S, Yunoki T, Deguchi S, Abe K.

Brain Res. 2012 Feb 3;1436:168-77. doi: 10.1016/j.brainres.2011.12.016. Epub 2011 Dec 16.

PMID:
22221736
2.

Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.

Zhang W, Sato K, Hayashi T, Omori N, Nagano I, Kato S, Horiuchi S, Abe K.

Neurol Res. 2004 Apr;26(3):342-8.

PMID:
15142331
3.

Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.

Deguchi K, Liu N, Liu W, Omote Y, Kono S, Yunoki T, Deguchi S, Yamashita T, Ikeda Y, Abe K.

J Neurosci Res. 2014 Nov;92(11):1509-19. doi: 10.1002/jnr.23420. Epub 2014 Jun 17.

4.

Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.

Lukic-Panin V, Deguchi K, Yamashita T, Shang J, Zhang X, Tian F, Liu N, Kawai H, Matsuura T, Abe K.

Curr Neurovasc Res. 2010 Nov;7(4):319-29.

PMID:
20854248
5.

[Therapeutic time window for ischemic stroke].

Abe K.

Rinsho Shinkeigaku. 2011 Nov;51(11):1182-4. Japanese.

PMID:
22277527
6.

Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.

Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2894-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.022. Epub 2014 Oct 3.

PMID:
25282183
7.

Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.

Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S.

Stroke. 2009 Feb;40(2):626-31. doi: 10.1161/STROKEAHA.108.520262. Epub 2008 Dec 18.

8.

Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.

Okamura K, Tsubokawa T, Johshita H, Miyazaki H, Shiokawa Y.

Neurol Res. 2014 Jan;36(1):65-9. doi: 10.1179/1743132813Y.0000000259. Epub 2013 Dec 6.

PMID:
24074041
9.

Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain.

Yamashita T, Kamiya T, Deguchi K, Inaba T, Zhang H, Shang J, Miyazaki K, Ohtsuka A, Katayama Y, Abe K.

J Cereb Blood Flow Metab. 2009 Apr;29(4):715-25. doi: 10.1038/jcbfm.2008.164. Epub 2009 Jan 14.

PMID:
19142198
10.

Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.

Zhang P, Li W, Li L, Wang N, Li X, Gao M, Zheng J, Lei S, Chen X, Lu H, Liu Y.

Neuroscience. 2012 Jan 10;201:297-306. doi: 10.1016/j.neuroscience.2011.11.005. Epub 2011 Nov 15.

PMID:
22116052
11.

Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke.

Sun YY, Morozov YM, Yang D, Li Y, Dunn RS, Rakic P, Chan PH, Abe K, Lindquist DM, Kuan CY.

PLoS One. 2014 Jun 9;9(6):e98807. doi: 10.1371/journal.pone.0098807. eCollection 2014.

12.

Combination drug therapy using edaravone and Daio-Orengedoku-to after transient focal ischemia in rats.

Cho KH, Oh JK, Jang YS, Jung JW, Oh HR, Park EK, Kim DH, Moon SK, Kim DH, Ryu JH.

Methods Find Exp Clin Pharmacol. 2008 Jul-Aug;30(6):443-50. doi: 10.1358/mf.2008.30.6.1241077.

PMID:
18850045
13.

In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice.

Liu N, Shang J, Tian F, Nishi H, Abe K.

Brain Res. 2011 Jun 23;1397:66-75. doi: 10.1016/j.brainres.2011.04.038. Epub 2011 Apr 27.

14.

The free-radical scavenger edaravone accelerates thrombolysis with alteplase in an experimental thrombosis model.

Yamashita T, Sato T, Sakamoto K, Ishii H, Yamamoto J.

Thromb Res. 2015 Jun;135(6):1209-13. doi: 10.1016/j.thromres.2015.04.011. Epub 2015 Apr 14.

PMID:
25908261
15.

Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia.

Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, Iwasaki Y.

Brain Res. 2004 Dec 17;1029(2):200-6.

PMID:
15542075
16.

In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone.

Tian F, Yamashita T, Deguchi K, Omote Y, Kawai H, Ohta Y, Abe K.

Neurol Res. 2013 Dec;35(10):1051-8. doi: 10.1179/1743132813Y.0000000252. Epub 2013 Aug 16.

PMID:
24070193
17.

Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.

Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D.

Basic Clin Pharmacol Toxicol. 2015 Nov;117(5):335-9. doi: 10.1111/bcpt.12413. Epub 2015 May 9.

18.

Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.

Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K.

Neuroscience. 2012 Sep 27;221:47-55. doi: 10.1016/j.neuroscience.2012.06.060. Epub 2012 Jul 3.

PMID:
22766232
19.

Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.

Takenaka K, Kato M, Yamauti K, Hayashi K.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2748-52. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.016. Epub 2014 Oct 11.

PMID:
25307430

Supplemental Content

Support Center